Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia

This publication has 30 references indexed in Scilit:

• The Helsinki Heart Study: Central Findings and Clinical Implications
  Annals of Medicine, 1991
• Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype
  Atherosclerosis, 1991
• Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapy
  European Journal of Clinical Investigation, 1987
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Application of SDS gradient polyacrylamide slab gel electrophoresis to analysis of apolipoprotein mass and radioactivity of rat lipoproteins
  Atherosclerosis, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
  JAMA, 1984
• Lipoprotein receptors and cholesterol homeostasis
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
• Ciprofibrate in the therapy of type II hypercholesterolemia A double-blind trial
  Atherosclerosis, 1982
• Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia
  Atherosclerosis, 1982
• The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug
  Atherosclerosis, 1979